Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.916
-0.005 (-0.59%)
At close: Dec 20, 2024, 4:00 PM
0.958
+0.042 (4.64%)
After-hours: Dec 20, 2024, 6:36 PM EST
Seres Therapeutics Employees
Seres Therapeutics had 233 employees as of December 31, 2023. The number of employees decreased by 198 or -45.94% compared to the previous year.
Employees
233
Change (1Y)
-198
Growth (1Y)
-45.94%
Revenue / Employee
$542,167
Profits / Employee
-$109,335
Market Cap
156.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Nutex Health | 800 |
The Joint | 794 |
Sutro Biopharma | 302 |
Cellectis | 221 |
Nkarta | 150 |
Nanobiotix | 102 |
Fennec Pharmaceuticals | 29 |
MCRB News
- 5 days ago - Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024 - GlobeNewsWire
- 2 months ago - Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A - GlobeNewsWire
- 3 months ago - Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé - Business Wire
- 3 months ago - Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30 - GlobeNewsWire
- 3 months ago - Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade - Seeking Alpha